Karyopharm Announces Refinancing Transactions $148M Of Existing Convertible Notes Due In 2025 To Be Exchanged for $111M Of New Convertible Notes Due In 2029 And Warrants, Issues New $100M Senior Secured Term Loan Due in 2028a
Karyopharm Announces Refinancing Transactions $148M Of Existing Convertible Notes Due In 2025 To Be Exchanged for $111M Of New Convertible Notes Due In 2029 And Warrants, Issues New $100M Senior Secured Term Loan Due in 2028a
Karyopharm宣布再融资交易2025年到期的现有可转换票据的1.48亿美元将交换2029年到期的1.11亿美元新可转换票据和认股权证，发行2028年到期的1亿美元新优先有担保定期贷款a
Karyopharm Announces Refinancing Transactions $148M Of Existing Convertible Notes Due In 2025 To Be Exchanged for $111M Of New Convertible Notes Due In 2029 And Warrants, Issues New $100M Senior Secured Term Loan Due in 2028a
Karyopharm宣布再融资交易2025年到期的现有可转换票据的1.48亿美元将交换2029年到期的1.11亿美元新可转换票据和认股权证，发行2028年到期的1亿美元新优先有担保定期贷款a
译文内容由第三方软件翻译。
以上内容仅用作资讯或教育之目的，不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。